Definition (What it is) of acellular dermal matrix
Acellular dermal matrix is a processed tissue scaffold made from dermis with living cells removed.
It is designed to support the body’s own tissue ingrowth and healing over time.
In plastic surgery, it is commonly used in both reconstructive and cosmetic procedures.
It is most widely discussed in breast surgery but also appears in other soft-tissue repairs.
Why acellular dermal matrix used (Purpose / benefits)
Acellular dermal matrix is used when surgeons want added support, coverage, or reinforcement for soft tissues. In many procedures, the clinician is working with thin, stretched, scarred, or previously operated tissue. In those settings, a scaffold can help create a more stable “platform” for healing and for shaping the final contour.
In breast reconstruction and augmentation-related revisions, acellular dermal matrix may be used to help define or reinforce the pocket that holds an implant, support the lower pole (the bottom portion of the breast), improve control of implant position, or add an extra layer between the skin and implant in selected cases. The overall goals tend to relate to shape, symmetry, and soft-tissue support rather than “volume replacement” in the way a filler or fat graft would provide.
In reconstructive settings outside the breast, acellular dermal matrix may be used to provide coverage over sensitive structures, to reinforce a repair, or to help close or rebuild areas where local tissue is limited. Because it is acellular, the intent is that it functions as a biologic scaffold that can integrate with the patient’s own tissue response over time, though the pace and degree of integration varies by material and manufacturer and by the clinical scenario.
Importantly, acellular dermal matrix is a tool, not a guarantee of a specific aesthetic result. The potential benefits depend on anatomy, surgical plan, tissue quality, and clinician technique, and may differ between cosmetic and reconstructive goals.
Indications (When clinicians use it)
Typical scenarios where clinicians may consider acellular dermal matrix include:
- Implant-based breast reconstruction (e.g., helping shape or support an implant pocket)
- Revision breast surgery for implant malposition (implant sitting too high, low, or to the side)
- Cases where additional soft-tissue reinforcement is desired due to thin tissue coverage
- Selected capsular contracture revision strategies (varies by clinician and case)
- Breast lift or augmentation-mastopexy revisions where pocket control is a priority
- Reconstruction after tissue loss (e.g., trauma, burns, oncologic surgery) where coverage is limited
- Soft-tissue reinforcement in certain abdominal wall or hernia-related reconstructions (more commonly general surgery, but relevant to reconstructive principles)
- Selected facial or body contour revision cases needing a biologic scaffold for support (less common and highly case-dependent)
Contraindications / when it’s NOT ideal
Acellular dermal matrix is not suitable for every patient or procedure. Situations where it may be avoided or used cautiously include:
- Active infection or uncontrolled contamination at the surgical site (risk considerations vary by clinician and case)
- Poor soft-tissue healing potential (for example, severely compromised blood supply), where any added material may increase complexity
- Uncontrolled systemic illness that increases surgical risk, where procedure simplification may be preferred
- Known allergy or sensitivity concerns related to processing agents or preservatives (rare; depends on product and history)
- When the added thickness or stiffness could compromise the intended contour in a thin patient (varies by material and placement)
- When a synthetic mesh, local tissue flap, fat grafting, or pocket revision alone is expected to meet goals with less added cost or complexity (varies by clinician and case)
- Patients who cannot meet follow-up needs or postoperative monitoring requirements for the underlying surgery
These are general considerations rather than rules. Whether acellular dermal matrix is appropriate depends on the primary operation, tissue quality, the specific product used, and the surgeon’s experience and preferences.
How acellular dermal matrix works (Technique / mechanism)
Acellular dermal matrix is used in surgical procedures rather than minimally invasive or non-surgical treatments. It is not an injectable filler and it is not an energy-based device; it does not tighten skin through heat or resurface skin like lasers. Instead, it is placed surgically as a sheet or shaped piece of biologic material.
At a high level, it works by acting as a scaffold. The clinician positions it where added support, coverage, or reinforcement is needed—often to help control shape, define a boundary (such as an implant pocket), or add a protective layer over delicate tissues. It can be sutured to surrounding structures to provide immediate mechanical support, and then the body’s healing response may gradually incorporate it.
Mechanistically, acellular dermal matrix is generally used to:
- Reinforce: strengthen a repair or thin tissue area
- Reposition/control: help guide where an implant or tissue sits by defining boundaries
- Restore support: add structural support in areas that have been stretched, thinned, or previously operated on
- Provide coverage: add a layer between an implant and skin/soft tissue in selected cases
Typical tools and modalities involved are the standard tools of surgery: incisions, dissection, sutures, and sometimes drains depending on the procedure and surgeon. The acellular dermal matrix itself is usually trimmed, oriented, and secured with sutures. The “effect” is therefore primarily structural support and soft-tissue reinforcement, with the final contour depending on overall surgical planning and healing.
acellular dermal matrix Procedure overview (How it’s performed)
The exact steps depend on the underlying operation (for example, breast reconstruction versus revision augmentation), but the workflow commonly follows a similar structure:
-
Consultation
The clinician reviews goals (cosmetic, reconstructive, or both), health history, prior surgeries, and expectations. They typically discuss where acellular dermal matrix might help (support, pocket control, coverage) and what tradeoffs it may add (cost, operative time, added implanted material). -
Assessment / planning
Planning is based on anatomy, skin and soft-tissue quality, scar patterns, and the intended result. In breast surgery, this may include assessing implant position, capsule characteristics, and the amount of existing tissue coverage. Product selection (type, thickness, size) varies by clinician and case. -
Prep / anesthesia
Because placement is surgical, anesthesia is dictated by the primary procedure. This may range from local anesthesia with sedation to general anesthesia, depending on extent and complexity. -
Procedure (placement and fixation)
The surgeon performs the main operation (e.g., reconstruction, revision, pocket adjustment). The acellular dermal matrix is then prepared (often hydrated/handled per manufacturer instructions), trimmed, positioned, and secured—commonly with sutures—to reinforce or define the targeted area. In implant-based surgery, it may be used as part of pocket creation or modification. -
Closure / dressing
Incisions are closed in layers. Dressings and supportive garments are used according to the primary surgery. Drains may be placed in some operations to manage fluid; this varies by clinician and case. -
Recovery and follow-up
Recovery is primarily determined by the underlying surgery rather than the acellular dermal matrix alone. Follow-up visits typically focus on wound healing, swelling, fluid collections, implant position (when applicable), and early detection of complications.
This overview is intentionally general; specific techniques and sequencing differ substantially between procedure types and surgical philosophies.
Types / variations
“Acellular dermal matrix” refers to a category rather than a single standardized product. Common distinctions include:
- Tissue source
- Human-derived (allograft): processed from donated human dermis.
-
Animal-derived (xenograft): commonly porcine (pig) or bovine (cow) dermis. Processing methods and final properties vary by material and manufacturer.
-
Processing and sterility
-
Products may be marketed as aseptically processed or terminally sterilized. The clinical implications can depend on the setting and surgeon preference; definitions and standards may vary by manufacturer.
-
Crosslinked vs non-crosslinked
-
Some matrices are crosslinked to alter strength and resistance to breakdown, while non-crosslinked options may be designed for different handling and integration characteristics. Tradeoffs can include feel, pliability, and remodeling behavior; outcomes vary by product and clinical context.
-
Thickness, size, and perforation
- Matrices come in different thicknesses (thin vs thick), which can affect handling and the amount of added bulk.
-
Some are perforated or meshed to improve fluid egress and conformability; others are solid sheets.
-
Placement strategy (technique variation)
- In breast procedures, acellular dermal matrix may be used to support the lower pole, reinforce the inframammary fold, create or reinforce a pocket, or add coverage in selected planes.
-
It can be combined with other methods such as pocket suturing techniques, capsular work, or fat grafting, depending on goals.
-
Surgical vs non-surgical
-
This category is surgical; there is no true non-surgical version of acellular dermal matrix placement comparable to injectables or energy-based tightening.
-
Anesthesia choices
- Anesthesia is determined by the overall operation: local with sedation may be possible for limited revisions in selected patients, while general anesthesia is common for larger reconstructions or combined procedures.
Pros and cons of acellular dermal matrix
Pros:
- Can provide added soft-tissue support where tissue is thin or previously operated on
- May improve control of contour and pocket boundaries in implant-based procedures (varies by clinician and case)
- Serves as a biologic scaffold intended for tissue ingrowth over time
- Can be shaped and tailored during surgery to match anatomy
- May reduce the need for more extensive tissue transfer in selected scenarios (case-dependent)
- Useful in both reconstructive and cosmetic revision contexts when support is a main issue
Cons:
- Adds cost and may increase operative complexity compared with suture-only approaches
- As an implanted material, it can be associated with complications such as infection, fluid collection (seroma), wound healing issues, or exposure (risk varies by case)
- Handling characteristics and remodeling can vary by material and manufacturer
- May add bulk or stiffness in some placements, which can be undesirable in very thin tissues
- Does not replace the role of good tissue quality; outcomes still depend on biology and technique
- May not address concerns driven primarily by skin laxity, overall weight change, or implant selection without additional procedures
Aftercare & longevity
Aftercare is mainly dictated by the primary surgery (for example, breast reconstruction, revision augmentation, or repair of soft-tissue loss). Swelling, bruising, and activity limitations vary by procedure extent, incision pattern, and whether drains are used. Follow-up visits are important for monitoring incision healing and early issues such as fluid collection, redness, or wound separation.
Longevity is best understood as durability of the overall repair rather than a simple “how long it lasts” timeline. Factors that can influence durability include:
- Surgical technique and placement plane, including how well the matrix is secured and supported
- Tissue quality and blood supply, especially in previously operated or irradiated areas (varies by clinician and case)
- Patient anatomy, including skin thickness and baseline laxity
- Lifestyle factors that can affect healing and tissue quality (for example, smoking status and overall health), though individual impact varies
- Weight stability and aging, which affect soft tissues over time
- Sun exposure (more relevant to skin quality in general than to deeper placement, but it can influence overlying tissue appearance)
- Adherence to follow-up and management of early healing problems
Because products and patient scenarios differ, the pace of remodeling and long-term behavior varies by material and manufacturer and by the specific clinical setting.
Alternatives / comparisons
The “alternative” to acellular dermal matrix depends on the problem being solved—support, coverage, pocket control, or contour.
-
Suture-based pocket repair (no added material)
For some implant malpositions or contour issues, surgeons may rely on capsular techniques and suturing alone to tighten, reshape, or reposition the pocket. This avoids adding an implanted scaffold but may be less robust in very thin or compromised tissue (varies by clinician and case). -
Synthetic mesh
Synthetic meshes can also provide reinforcement and are used widely in many surgical fields. Compared with acellular dermal matrix, synthetics may have different handling, cost, and infection-related considerations depending on the setting. Choice often reflects surgeon preference, contamination risk, and desired mechanical properties. -
Autologous tissue (patient’s own tissue)
- Local tissue flaps: rearranging nearby tissue to provide coverage and support.
-
Free flaps (in reconstruction): transferring tissue from another part of the body to rebuild volume and skin/soft tissue.
These can provide durable living tissue but are typically more complex operations with different recovery profiles. -
Fat grafting (autologous fat transfer)
Fat grafting is often used to improve soft-tissue thickness, camouflage implant edges, or refine contour. It provides volume and softening rather than a sheet-like structural scaffold. It can be combined with acellular dermal matrix in some plans, depending on goals. -
Non-surgical options (limited relevance)
For concerns like mild contour irregularities or skin texture, non-surgical treatments (injectables, laser, radiofrequency, ultrasound) may be discussed. However, they do not replicate the structural support role of acellular dermal matrix and are not substitutes when pocket control or tissue reinforcement is the primary issue.
A balanced comparison usually comes down to the underlying problem (support vs volume vs skin), tissue quality, risk tolerance, cost considerations, and the surgeon’s experience.
Common questions (FAQ) of acellular dermal matrix
Q: Is acellular dermal matrix the same as a skin graft?
No. A skin graft is placed to replace skin coverage on the surface, while acellular dermal matrix is a processed dermal scaffold typically placed surgically to reinforce or support deeper soft tissues. They can be used in related reconstructive contexts, but they are not interchangeable.
Q: Where is acellular dermal matrix most commonly used in plastic surgery?
It is commonly discussed in breast reconstruction and implant-related revision surgery, where surgeons may use it to help shape or reinforce the implant pocket. It may also be used in other soft-tissue reconstruction settings when added support or coverage is needed.
Q: Does acellular dermal matrix dissolve or stay in the body forever?
It is generally intended to act as a scaffold that remodels and integrates with the patient’s tissues over time. The degree and timing of remodeling varies by material and manufacturer and by the clinical scenario, so there isn’t a single universal timeline.
Q: Is the procedure painful?
Discomfort usually relates more to the primary surgery (such as reconstruction or revision) than to the matrix itself. Pain experience varies by individual, surgical extent, and anesthesia approach. Clinicians typically plan pain control as part of the overall operation.
Q: What kind of anesthesia is used?
Placement is surgical, so anesthesia depends on the procedure’s complexity. Some limited revisions may be performed with local anesthesia and sedation, while many reconstructions and major revisions are performed under general anesthesia. The choice varies by clinician and case.
Q: Will there be scarring?
Scars come from the incisions required for the underlying surgery, not specifically from acellular dermal matrix. Scar location and length depend on the procedure type (for example, breast reconstruction patterns versus revision incisions) and individual healing.
Q: How long is downtime and recovery?
Recovery timelines are driven primarily by the main operation and whether it is combined with other procedures. Swelling and activity limits can vary widely, and follow-up needs may differ if drains are used. Your clinician’s protocol may differ based on technique and case specifics.
Q: Is acellular dermal matrix “safe”?
All surgical materials and procedures carry risks. Acellular dermal matrix is widely used, but potential complications can include infection, fluid collection, wound healing issues, or problems related to the underlying implant or reconstruction plan. Risk varies by clinician and case, and by patient health factors.
Q: Does acellular dermal matrix prevent capsular contracture?
Some surgeons incorporate it as part of broader strategies in selected revision or reconstruction cases, but it should not be viewed as a guarantee against capsular contracture. Capsular contracture is multifactorial, and outcomes vary by technique, implant factors, and individual biology.
Q: How much does acellular dermal matrix cost?
Costs vary widely by region, facility, procedure type, product selection, and whether it is used in reconstruction or cosmetic revision. It may add material and operating room costs compared with techniques that do not use an added scaffold. Exact pricing is typically specific to the surgical plan and setting.
Q: Can acellular dermal matrix be used with fat grafting or implants?
Yes, it may be used alongside implants and may be combined with fat grafting in selected cases to address different goals (support vs soft-tissue thickness/contour). Whether combination is appropriate depends on anatomy, tissue quality, and the clinician’s plan.